C84.77
Anaplastic large cell lymphoma, ALK-negative, spleen
Clinical Classification Guidelines
Medical Intelligence & Overview
Anaplastic large cell lymphoma (ALCL) is a type of non-Hodgkin lymphoma—a cancer that originates in the lymphatic system. Specifically, the ALK-negative subtype refers to cases where the cancer cells do not produce an abnormal enzyme called anaplastic lymphoma kinase (ALK). When this disease affects the spleen, it can cause various symptoms and requires careful diagnostic evaluation. The ICD-10 code C84.77 is used for medical classification purposes to identify this specific condition.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to abnormal cell growth Previous exposure to certain chemicals or radiation Infections that may trigger lymphoma development Unknown factors in many cases
Key Symptoms: Swelling or enlargement of the spleen (splenomegaly) Unexplained weight loss Persistent fever Night sweats Fatigue or weakness Frequent infections due to immune system impairment Pain or discomfort in the upper left abdomen
Diagnostic & Treatment
Diagnosis Path: Diagnosing anaplastic large cell lymphoma of the spleen involves a series of medical evaluations, including:
Treatment Protocols: Treatment options for anaplastic large cell lymphoma, ALK-negative, of the spleen typically involve chemo- and immunotherapy approaches tailored to the patient's condition:
Clinical Advice & FAQs
Billing Guidance
Is C84.77 a billable ICD-10 code?
Yes, C84.77 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.77?
Clinical documentation must specify the nature of Anaplastic large cell lymphoma, ALK-negative, spleen and any associated comorbidities for accurate reporting.
Cite this Clinical Reference